Patent · US Active

Method for determining the anti-tumor efficacy of monoclonal antibodies

US9339560B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Birgit Bossenmaier · Hanerau-Hademarschen, DE
Valeria Lifke · Penzberg, DE
Werner Scheuer · Penzberg, DE

Key dates

Filing date	Sep 21, 2009
Grant date	May 17, 2016
Priority date	—
Expiry date	Oct 5, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for determining the anti-tumor efficacy of monoclonal antibodies in pre-clinical rodent testings and the use of said method for the reduction of side testings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.